BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38012581)

  • 1. Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy.
    Lu Z; Ni H; Yang X; Tan L; Zhuang H; Mo Y; Wei X; Qi L; Xiang B
    BMC Cancer; 2023 Nov; 23(1):1150. PubMed ID: 38012581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood.
    Wang Z; Luo L; Cheng Y; He G; Peng B; Gao Y; Jiang ZS; Pan M
    J Gastrointest Surg; 2018 Apr; 22(4):633-639. PubMed ID: 29159757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
    Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
    BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors.
    Wei HW; Qin SL; Xu JX; Huang YY; Chen YY; Ma L; Qi LN
    Cancer Med; 2023 Jul; 12(14):15065-15078. PubMed ID: 37337754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive values of serum dickkopf-1 and circulating tumor cells in evaluating the efficacy of transcatheter arterial chemoembolization treatment on hepatocellular carcinoma.
    Wu X; Yang C; Yu H; Cao F; Shan Y; Zhao W
    Medicine (Baltimore); 2019 Jul; 98(30):e16579. PubMed ID: 31348291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma.
    Zhao L; Zheng Z; Liu Y; Liu F; Li X; Wu Z
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6035-6048. PubMed ID: 36633681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Platelet Count is a Potential Prognostic Factor of the Early Recurrence of Hepatocellular Carcinoma in the Presence of Circulating Tumor Cells.
    Lu Z; Huang Y; Huang J; Ni HH; Luo T; Wei X; Bai X; Qi L; Xiang B
    J Hepatocell Carcinoma; 2023; 10():57-68. PubMed ID: 36685111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
    Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
    BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
    Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
    Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
    Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
    Ni HH; Yang XH; Yang CL; Zhang Q; Xu JX; Qi LN; Xiang BD
    Biomed Res Int; 2022; 2022():7305953. PubMed ID: 35880030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis.
    He YZ; He K; Huang RQ; Wang ZL; Ye SW; Liu LW; Luo QJ; Hu ZM
    Ann Hepatol; 2020; 19(6):654-661. PubMed ID: 32768591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection.
    Sun YF; Wang PX; Cheng JW; Gong ZJ; Huang A; Zhou KQ; Hu B; Gao PT; Cao Y; Qiu SJ; Zhou J; Fan J; Guo W; Yang XR
    Cancer Cytopathol; 2020 Oct; 128(10):733-745. PubMed ID: 32501632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells.
    Lai HC; Yeh CC; Jeng LB; Huang SF; Liao PY; Lei FJ; Cheng WC; Hsu CL; Cai X; Chang C; Ma WL
    Oncotarget; 2016 Jul; 7(29):46448-46465. PubMed ID: 27340775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis.
    Zhang Y; Shi ZL; Yang X; Yin ZF
    World J Gastroenterol; 2014 Jan; 20(1):142-7. PubMed ID: 24415867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.
    Cheng Y; Luo L; Zhang J; Zhou M; Tang Y; He G; Lu Y; Wang Z; Pan M
    J Gastrointest Surg; 2019 Dec; 23(12):2354-2361. PubMed ID: 30805878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
    Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
    Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses.
    Yin LC; Luo ZC; Gao YX; Li Y; Peng Q; Gao Y
    Biomed Res Int; 2018; 2018():3789613. PubMed ID: 30046595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.